María Eva Mingot-Castellano Selected Research

María Eva Mingot-Castellano Research Topics

8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2024 - 03/2015
6	Hemorrhage 04/2024 - 05/2016
4	Hemophilia A (Haemophilia) 02/2024 - 05/2016
3	von Willebrand Diseases (von Willebrand's Disease) 03/2020 - 01/2018
2	Thrombosis (Thrombus) 04/2024 - 03/2015
2	Thrombocytopenia (Thrombopenia) 11/2023 - 06/2022
2	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 01/2022
2	Thrombotic Thrombocytopenic Purpura 12/2022 - 06/2022
2	Evans Syndrome 06/2022 - 12/2021
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 06/2022 - 12/2021
1	Thrombotic Microangiopathies 12/2022
1	Rare Diseases (Rare Disease) 01/2022
1	Infections 12/2021
1	Neutropenia 12/2021
1	Cytopenia 12/2021
1	Disease Progression 12/2021
1	Type 2 von Willebrand Disease 11/2021
1	Diarrhea 03/2015

7	Inosine Triphosphate (ITP)IBA 04/2024 - 03/2015
4	Factor VIII (Coagulation Factor VIII)IBA 11/2021 - 05/2016
3	von Willebrand FactorIBA 11/2021 - 01/2018
2	AntibodiesIBA 02/2024 - 12/2022
2	eltrombopag FDA Link 04/2015 - 03/2015
1	fostamatinibIBA 04/2024
1	Thrombopoietin (c-mpl Ligand)IBA 11/2023
1	caplacizumabIBA 12/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022
1	AutoantibodiesIBA 06/2022
1	VaccinesIBA 06/2022
1	AnticoagulantsIBA 01/2022
1	Factor VIIa (Activated Factor VII)IBA 07/2020
1	Prothrombin (Factor II)IBA 07/2020
1	recombinant FVIIa (rFVIIa)FDA Link 07/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	romiplostim FDA Link 04/2015
1	4,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA 04/2015
1	Thrombopoietin ReceptorsIBA 04/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2015

6	Therapeutics 04/2024 - 05/2016
1	Minor Surgical Procedures (Minor Surgery) 05/2016